Ainos Corporation (AIMD) Price to Earnings Ratio

Corporate emblem and logo of Ainos Corp (AIMD)

As reflected in the pakistan chart, the asset value of Ainos, Inc. (AIMD) on GURU.Markets stands at -0.60, illustrating the company's operations in the field of laboratory diagnostics. Strategic reserves and long-term agreements ensure the stability of component supplies. The business relies on steady demand for rapid tests, which persists regardless of economic fluctuations. The company's innovations are based on digital breath analysis and cloud integration with telemedicine.

AIMD Ainos: Price to Earnings Ratio in the range 04/28/2023 - 11/14/2026

Analytical breakdowns for Ainos, Inc.

- price and consensus price forecast:
Summary company analysis:AIMD, Ainos
Manufactured product of Ainos, Inc.

The P/E ratio determines the cost of a single unit of profit, allowing an investor to assess the degree of overpayment for an asset and the probability of default through the lens of market value. By analyzing the expected P/E of Ainos, Inc. (AIMD) at -0.60, one can identify overvaluation risks for Ainos, Inc., whose stability is constrained by costly R&D expenditures and fierce competition in the portable diagnostics segment.

Key competitors

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|Nordion (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Health Inc|CareDx (CDNA) - Business Payback Period|Price to Earnings Ratio Maravai LifeSciences Holdings (MRVI)|FLGT: Market Cap to Net Income|P/E Multiple LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Market Cap to Earnings|OraSure Corp - P/E Multiple|Market Cap to Net Income Ratio exagen.com (XGN)|MDXH: P/E Multiple|LUCD - Business Payback Period|Price to Earnings Ratio PRE|IMDX - Market Cap to Net Income Ratio|Price to Earnings Ratio TRIB (Trinity Biotech plc)|P/E Multiple prophaselabs.com (PRPH)|P/E Multiple CODX (codiagnostics.com)|Market Price to Net Income Ratio HSCS (HeartSciences)|Biomerica Inc - P/E Multiple|CDIO (cardiodiagnosticsinc.com) - Price to Earnings Multiple|ONCO (Onconetix) - Price to Earnings Ratio|Market Cap to Earnings viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple